Subtype
Prostate Neuroendocrine Neoplasm
CI-CAN-00001444Explore in graph →
Non-malignant8 active trials
Loading cancer entity…
Subtype
CI-CAN-00001444Explore in graph →
Clinical trials
12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01505868 | Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 170 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Jul 30, 2021source: clinicaltrials